Taysha Gene Therapies' positive results from the REVEAL study showcase TSHA-102's promise in treating Rett Syndrome. Click ...

Precision diagnostics in prostate cancer treatment (PREDICT): A phase 2 multi-arm biomarker-based study (Alliance A032102). This is an ASCO Meeting Abstract from the 2025 ASCO Genitourinary Cancers ...

Stratum A (post-neoadjuvant) 83.1 (77.1-87.8) 76.6 (69.6-82.1) 0.67 (0.44-1.03) 0.06 Clinical trial identification: EUDRACT 2016-000189-45. Legal entity responsible for the study: Department of ...

This move has sparked significant legal challenges, with federal judges in Maryland, Massachusetts, and Washington issuing nationwide injunctions, citing violations of the 14th Amendment.

HG-CT-1 is the Company's CAR-T therapy, currently undergoing clinical trials in adults for the treatment of R/R AML. This amendment, filed with the U.S. Food and Drug Administration (FDA), seeks ...

HG-CT-1 is the Company's CAR-T therapy, currently undergoing clinical trials in adults for the treatment of R/R AML. This amendment, filed with the U.S. Food and Drug Administration (FDA), seeks ...

LONDON, UNITED KINGDOM / ACCESS Newswire / May 14, 2025 / Hemogenyx Pharmaceuticals plc (LSE:HEMO) is pleased to announce that it has filed an amendment to the clinical protocol for its ongoing Phase ...

New Delhi: The Subject Expert Committee (SEC) functional under the Central Drug Standard Control Organisation (CDSCO) has approved the proposal presented by Novartis Healthcare for protocol amendment ...

Methods and analysis We designed this protocol according to the Standard Protocol Items: Recommendations for Interventional Trials guidelines as a phase II, single-centred, single group and ...

Based on one trial, use of the microaxial flow pump in selected patients ... The ACC/AHA Joint Committee on Clinical Practice Guidelines (Joint Committee) continuously reviews, updates, and modifies ...

Moderna’s combined Covid and flu shot outperformed the existing standalone vaccines for both viruses, according to the results of a phase 3 clinical trial published Wednesday in the Journal of ...

Clinical trials of a new, minimally invasive treatment for degenerated spinal discs have produced impressive results, significantly reducing back pain severity and improving function. It could ...